Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000446

Type of data
NGS (WGS, Exome, RNA-seq, Target Capture)
Access criteria
Controlled-access (Type I)
Total data volume
7.5 TB
File formats
  • FASTQ
  • BAM
Research
hum0094
Date published
2022-05-17
Date modified
2026-09-26

Analysis method

WGS

Materials and participants
Colorectal cancer (ICD10: C189): 21 cases (including 3 cases used for WES, 18 cases used for TGS)
  • Health status
    Affected
  • Subject count
    21 (Individual)
Disease
Colorectal cancer (C189)
Sample description
DNAs extracted from tumor and non-tumor tissues
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WGS
Target
N/A
Reagent kit
TruSeq DNA PCR-Free Library Prep Kit
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp
Reference genome
GRCh38
Phenotype data
Included

WES

Materials and participants
Colorectal cancer (ICD10: C189): 128 cases [141 samples]
  • Health status
    Affected
  • Subject count
    128 (Individual)
Disease
Colorectal cancer (C189)
Sample description
DNAs extracted from tumor tissues and paired non-tumor tissues or peripheral blood cells as non-tumor tissues
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
NEBNext Ultra DNA Library Prep Kit for Illumina
SureSelect Human All Exon V5
SureSelect Human All Exon V6
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina HiSeq 2000
Illumina HiSeq 2500
Illumina NovaSeq 6000
Read type
Paired-end
Read length
Colorectal cancer: 125 bp
150 bp
151 bp
Reference genome
GRCh37
GRCh38

RNA-seq

Materials and participants
Colorectal cancer (ICD10: C189): 141 cases [170 samples] (including 14 cases used for RNA-seq only)
  • Health status
    Affected
  • Subject count
    141 (Individual)
Disease
Colorectal cancer (C189)
Sample description
RNAs extracted from tumor tissues
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
NEBNext Ultra Directional RNA Library Prep Kit for Illumina
TruSeq RNA Exome
Fragmentation
Heat treatment
Platform
Illumina HiSeq 2000
Illumina HiSeq 2500
Read type
Paired-end
Read length
Colorectal cancer: 125 bp
127 bp

Targeted DNA sequencing

Materials and participants
Colorectal cancer (ICD10: C189): 31 cases [49 samples]
  • Health status
    Affected
  • Subject count
    31 (Individual)
Disease
Colorectal cancer (C189)
Sample description
DNAs extracted from tumor tissues and paired non-tumor tissues (FFPE)
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
Todai OncoPanel
http://todaioncopanel.umin.jp/
Reagent kit
SureSelect Custom
Fragmentation
Heat treatment
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
Colorectal cancer: 125 bp
Reference genome
GRCh38